Mersana Therapeutics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Mersana Therapeutics, Inc. annual/quarterly Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Mersana Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2019 was $514K.
  • Mersana Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $4.03M, a 4.24% increase from 2022.
  • Mersana Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $3.87M, a 19.3% increase from 2021.
  • Mersana Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $3.24M, a 35.4% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.03M +$164K +4.24% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $3.87M +$624K +19.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 $3.24M +$847K +35.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-28
2020 $2.39M +$123K +5.42% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
2019 $2.27M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.